The role of receptor for advanced glycation end products (RAGE) in the proliferation of hepatocellular carcinoma

International Journal of Molecular Sciences

Volumn 13, Issue 5, 2012, Pages 5982-5997

  Yaser, Al Madhagi ^a   Huang, Yan ^a   Zhou, Rong Rong ^a   Hu, Guan Sheng ^a   Xiao, Mei Fang ^a   Huang, Zhe Bing ^a   Duan, Chao Jun ^a   Tian, Wei ^b   Tang, Dao Lin ^c   Fan, Xue Gong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

HMGB1; NF b; Proliferation; RAGE; SiRNA

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BETA ACTIN; DNA; HIGH MOBILITY GROUP B1 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; HMGB1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; MOK PROTEIN, HUMAN; RELA PROTEIN, HUMAN; TUMOR ANTIGEN;

ADULT; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING; BLOOD; GENETICS; HEPG2 CELL LINE; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

ADULT; ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HMGB1 PROTEIN; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; TRANSCRIPTION FACTOR RELA; UP-REGULATION;

EID: 84861540170     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13055982     Document Type: Article

References (35)

1. Hiwatashi, K.; Ueno, S.; Abeyama, K.; Kubo, F.; Sakoda, M.; Maruyama, I.; Hamanoue, M.; Natsugoe, S.; Aikou, T. A novel functions of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC. Ann. Surg. Oncol. 2007, 15, 923-933.
2. Kumar, V.; Fausto, N.; Abbas, A. Robbins & Cotran Pathologic Basis of Disease, 7th ed.; Saunders: Philadelphia, PA, USA, 2003; pp. 914-917.
3. Yang, X.J.; Zhang, Y.C.; Zhang, L.Y.; Lin, Z.; Mao, J. Silencing α-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell. Cancer Lett. 2008, 271, 281-293.
4. Srikrishna, G.; Huttunen, H.J.; Johansson, L.; Weigle, B.; Yamaguchi, Y.; Rauvala, H.; Freeze, H.H. N-glycans on the receptor for advanced glycan end products influence amphoterin binding and neurite outgrowth. J. Neurochem. 2002, 80, 998-1008.
5. Logsdon, C.D.; Fuentes, M.K.; Huang, E.H.; Arumugam, T. RAGE and RAGE ligands in cancer. Curr. Mol. Med. 2007, 7, 777-789.
6. Clynes, R.; Moser, B.; Yan, S.F.; Ramasamy, R.; Herold, K.; Schmidt, A.M. Receptor for AGE (RAGE): Weaving tangled webs within the inflammatory response. Curr. Mol. Med. 2007, 7, 743-751.
7. Yan, S.F.; Ramasamy, R.; Schmidt, A.M. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J. Mol. Med. 2009, 87, 235-247.
8. Chen, X.; Walker, D.G.; Schmidt, A.M.; Arancio, O.; Lue, L.F.; Yan, S.D. RAGE: A potential target for Abeta-mediated cellular perturbation in Alzheimer's disease. Curr. Mol. Med. 2007, 7, 735-742.
9. Bierhaus, A.; Humpert, P.; Morcos, M.; Wendt, T.; Chavakis, T.; Arnold, B.; Stern, D.; Nawroth, P. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005, 83, 876-886.
10. Hudson, B.I.; Kalea, A.Z.; Arriero, M.D.; Harja, E.; Boulanger, E.; D'Agati, V.; Schmidt A.M. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J. Biol. Chem. 2008, 283, 34457-34468.
11. Demling, N.; Ehrhardt, C.; Kasper, M.; Laue, M.; Knels, L.; Rieber, E. Promotion of cell adherence and spreading: A novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells. Cell Tissue Res. 2006, 323, 475-488.
12. Ramasamy, R.; Yan, S.F.; Schmidt, A.M. Arguing for the motion: Yes, RAGE is a receptor for advanced glycation end products. Mol. Nutr. Food Res. 2007, 51, 1111-1115.
13. Thomas, J.O.; Travers, A.A. HMG1 and 2, and related "architectural" DNA-binding proteins. Trends Biochem. Sci. 2001, 26, 167-174.
14. Ellerman, J.E.; Brown, C.K.; de Vera, M.; Zeh, H.J.; Billiar, T.; Rubartelli, A.; Lotze, M.T. Masquerader: High mobility group box-1 and cancer. Clin. Cancer Res. 2007, 13, 2836-2848.
15. Klune, J.R.; Dhupar, R.; Cardinal, J.; Billiar, T.R.; Tsung, A. HMGB1: Endogenous danger signaling. Mol. Med. 2008, 14, 476-484.
16. Palumbo, R.; Sampaolesi, M.; de Marchis, F.; Tonlorenzi, R.; Colombetti, S.; Mondino, A.; Cossu, G.; Bianchi, M.E. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 2004, 164, 441-449.
17. Scaffidi, P.; Misteli, T.; Bianchi, M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418, 191-195.
18. Wang, H.; Bloom, O.; Zhang, M.; Vishnubhakat, J.M.; Ombrellino, M.; Che, J.; Frazier, A.; Yang, H.; Ivanova, S.; Borovikova, L. et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285, 248-251.
19. Yeh, C.H.; Sturgis, L.; Haidacher, J.; Zhang, X.N.; Sherwood, S.J.; Bjercke, R.J.; Juhasz, O.; Crow, M.T.; Tilton, R.G.; Denner, L. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE mediated nuclear factor-κB transcriptional activation and cytokine secretion. Diabetes 2001, 50, 1495-504.
20. Huttunen, H.J.; Fages, C.; Rauvala, H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 1999, 274, 19919-19924.
21. Schmid, R.M.; Adler, G. NF-κB/rel/IκB, Implications in gastrointestinal diseases. Gastroenterology 2000, 118, 1208-1228.
22. Karin, M.; Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu. Rev. Immunol. 2000, 18, 621-663.
23. Cheng, Q.; Cant, C.A.; Moll, T.; Hofer-Warbinek, R.; Wagner, E.; Birnstiel, M.L.; Bach, F.H.; de Martin R. NK-kappa B subunit-specific regulation of the I kappa B alpha promoter. J. Biol. Chem. 1994, 269, 13551-13557.
24. Deane, N.G.; Parker, M.A.; Aramandla, R.; Diehl, L.; Lee, W.-J.; Washington, M.K; Nanney, L.B.; Shyr, Y.; Beauchamp R.D. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res. 2001, 61, 5389-5395.
25. Hsieh, H.L.; Schafer, B.W.; Sasaki, N.; Heizmann, C.W. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem. Biophys. Res. Commun. 2003, 307, 375-381.
26. Flohr, A.M.; Rogalla, P.; Meiboom, M.; Borrmann, L.; Krohn, M.; Thode-Halle, B.; Bullerdiek, J. Variation of HMGB1 expression in breast cancer. Anticancer Res. 2001, 21, 3881-3885.
27. Kuniyasu, H.; Yano, S.; Sasaki, T.; Sasahira, T.; Sone, S.; Ohmori, H. Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages. Am. J. Pathol. 2005, 166, 751-760.
28. Ishiguro, H.; Nakaigawa, N.; Miyoshi, Y.; Fujinami, K.; Kubota, Y.; Uemura, H. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. Prostate 2005, 64, 92-100.
29. Takada, M.; Hirata, K.; Ajiki, T.; Suzuki, Y.; Kuroda, Y. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepatogastroenterology 2004, 51, 928-930.
30. Kuniyasu, H.; Oue, N.; Wakikawa, A.; Shigeishi, H.; Matsutani, N.; Kuraoka, K.; Ito, R.; Yokozaki, H.; Yasui, W. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J. Pathol. 2002, 196, 163-170.
31. Kuniyasu, H.; Chihara, Y.; Kondo, H. Differential effects between amphoterin and advanced glycation end products on colon cancer cells. Int. J. Cancer 2003, 104, 722-727.
32. Poser, I.; Bosserhoff, A.K. Transcription factors involved in development and progression of malignant melanoma. Histol. Histopathol. 2004, 19, 173-188.
33. Daolin, T.; Rui, K.; Herbert, J.Z.; Michael T.L. High-mobility group box 1 and cancer. Biochim. Biophys. Acta 2010, 1799, 131-140.
34. Hinz, M.; Krappmann, D.; Eichten, A.; Heder, A.; Scheidereit, C.; Strauss, M. NF-κB function in growth control, Regulation of cyclin D1 expression and G0/G1-to-S-Phase transition. Mol. Cell. Biol. 1999, 19, 2690-2698.
35. Li, J.; Schmidt, A.M. Characterization and functional analysis of the promoter of RAGE. J. Biol.Chem. 1997, 272, 16498-16506.